Biblio

Koetsier KS, Hensen EF, Niemierko A, Dewyer NA, Chapman PH, Lamba N, Bussière MR, van Vulpen M, McKenna MJ, Loeffler JS et al..  2021.  Outcome and Toxicity of Proton Therapy for Vestibular Schwannoma: A Cohort Study.. Otol Neurotol. 42(10):1560-1571.

Beswick DM, Hwang PH, Adappa ND, Le CH, DO IMHumphrey, Getz AE, Suh JD, Aasen DM, Abuzeid WM, Chang EH et al..  2021.  Surgical approach is associated with complication rate in sinonasal malignancy: A multicenter study.. Int Forum Allergy Rhinol. 11(12):1617-1625.

Boyd C, Shew M, Penn J, Muelleman T, Lin J, Staecker H, Wichova H.  2020.  Postoperative Opioid Use and Pain Management Following Otologic and Neurotologic Surgery.. Ann Otol Rhinol Laryngol. 129(2):175-180.

Xu MJue, Plonowska KA, Gurman ZR, Humphrey AK, Ha PK, Wang SJ, El-Sayed IH, Heaton CM, George JR, Yom SS et al..  2020.  Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancer.. Laryngoscope. 130(2):E48-E56.

Sun L, Chin R-I, Gastman B, Thorstad W, Yom SS, Reddy CA, Nussenbaum B, Wang SJ, Knackstedt T, Vidimos AT et al..  2019.  Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.. JAMA Dermatol. 155(4):442-447.

Han JE, Yi SK, Wang S, Erman A, Bearelly S, Sindhu S, Robbins JR, Bauman J, Hsu CC.  2019.  Neoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 disease.. Head Neck. 41(12):4076-4087.